Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BME/GRF stock hub

BME/GRF has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BME/GRFis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.6B

Madrid Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BME/GRF

In the news

Latest news · BME/GRF

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.5

P25 13.9P50 15.9P75 23.2

Trailing P/E14.7

P25 19P50 22.9P75 51.7

ROE6.1

P25 -2.5P50 6.1P75 23.1

ROIC6.7

P25 -1.5P50 7.5P75 17.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BME/GRF market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

234

Groups with data

Currency

EUR

Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Spain
Country code	ES
Employees	25,258
Employees Change	1,425%
Employees Change Percent	5.98
Enterprise value	EUR 16.9B
Exchange	Madrid Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	ES0171996087
Last refreshed	2026-05-10
Market cap	EUR 5.6B
Price	EUR 8.94
Price currency	EUR
Rev Per Employee	297,520x
Sector	Healthcare
Sic	2836
Symbol	bme/GRF
Website	https://www.grifols.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.47%
EV Earnings	40.75x
EV/EBIT	12.24x
EV/EBITDA	9.62x
EV/FCF	22.46x
EV/Sales	2.27x
FCF yield	13.56%
Forward P/E	9.47x
P/B ratio	0.71x
P/E ratio	14.66x
P/S ratio	0.75x
PE Ratio10 Y	46.3x
PE Ratio3 Y	69.86x
PE Ratio5 Y	69.05x
PEG ratio	0.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.58%
EBITDA Margin	22.54%
FCF margin	10.12%
Gross margin	38.36%
Gross Profit	EUR 2.9B
Gross Profit Growth	-1.74%
Gross Profit Growth Q	-9.31%
Gross Profit Growth3 Y	7.59%
Gross Profit Growth5 Y	5.36%
Net Income	EUR 415M
Net Income Growth	112.57%
Net Income Growth Q	22.23%
Net Income Growth Quarters	6%
Net Income Growth Years	2%
Net Income Growth3 Y	107.13%
Net Income Growth5 Y	-5.89%
Pretax Margin	8.21%
Profit Margin	5.58%
Profit Per Employee	EUR 16,600
Profitable Years	21
ROA	4.21
Roa5y	2.87
ROCE	7.7
ROE	6.13
Roe5y	3.59
ROIC	6.74
Roic5y	4.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.17%
Cagr15y	2.56%
Cagr1y	10.47%
Cagr3y	-1.7%
Cagr5y	-17.07%
Div CAGR10	-6.9%
Div CAGR3	0%
Div CAGR5	-22.19%
EPS Growth Quarters	6
EPS Growth Years	2
EPS Growth5 Y	-5.74
FCF Growth	-21.47%
FCF Growth Q	-32.81%
FCF Growth5 Y	-3.74%
OCF Growth	-15.1%
OCF Growth Q	-18.8%
OCF Growth10 Y	2.9%
OCF Growth5 Y	-2.9%
Revenue Growth	0.89x
Revenue Growth Q	-4.81x
Revenue Growth Years	4x
Revenue Growth3 Y	5.37x
Revenue Growth5 Y	7.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.36
Assets	EUR 20.1B
Cash	EUR 702M
Current Assets	EUR 5.3B
Current Liabilities	EUR 2.1B
Debt	EUR 9.7B
Debt EBITDA	EUR 5.5
Debt Equity	EUR 1.23
Debt FCF	EUR 12.84
Equity	EUR 7.8B
Interest Coverage	2.46
Liabilities	EUR 12.2B
Long Term Assets	EUR 14.8B
Long Term Liabilities	EUR 10.1B
Net Cash	EUR -9B
Net Cash By Market Cap	EUR -161
Net Debt EBITDA	EUR 5.35
Net Debt Equity	EUR 1.14
Net Debt FCF	EUR 11.91
Tangible Book Value	EUR -5.2B
Tangible Book Value Per Share	EUR -7.59
WACC	6.88

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.47
Inventory Turnover	1.31
Net Working Capital	EUR 3B
Quick ratio	0.78
Working Capital	EUR 3.1B
Working Capital Turnover	EUR 2.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	EUR 0.3
Dividend Years	1
Dividend Yield	3.36%
Ex Div Date	2025-08-11
Last Dividend	EUR 0.12
Payout Frequency	Annual
Payout Ratio	30.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-47.12%
1Y total return	10.46%
200-day SMA	10.95
3Y total return	-5%
50-day SMA	9.34
50-day SMA vs 200-day SMA	50under200
5Y total return	-60.78%
All Time High	34.31
All Time High Change	-73.94%
All Time High Date	2020-02-20
All Time Low	2.35
All Time Low Change	280.43%
All Time Low Date	2006-05-23
ATR	0.27
Beta	1.17
Beta1y	0.81
Beta2y	0.78
Ch YTD	-16.45
High	9.06
High52	13.7
High52 Date	2025-07-31
High52ch	-34.74%
Low	8.72
Low52	8.01
Low52 Date	2025-05-12
Low52ch	11.61%
Ma50ch	-4.25%
Price vs 200-day SMA	-18.33%
RSI	43.88
RSI Monthly	43.45
RSI Weekly	36.2
Sharpe ratio	0.06x
Sortino ratio	0.28
Total Return	3.36%
Tr YTD	-16.45
Tr15y	46.13%
Tr1m	-1.19%
Tr1w	-1.82%
Tr3m	-17.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 1.4B
Operating Income Growth	0.83
Operating Income Growth Q	-4.51
Operating Income Growth3 Y	34.49
Operating Income Growth5 Y	8.79
Operating margin	18.58

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	417,315,300%
Net Borrowing	-272,000,000
Shares Insiders	2.14%
Shares Institutions	46.48%
Shares Out	680,575,312
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 753M
Average Volume	2,361,743.65x
Bv Per Share	8.02
CAPEX	EUR -268M
Ch10y	-50.93
Ch15y	31.76
Ch1m	-1.19
Ch1w	-1.82
Ch1y	9.43
Ch3m	-17.76
Ch3y	-5.89
Ch5y	-61.66
Ch6m	-13.79
Change	-2.36%
Change From Open	-0.45
Close	9.16
Days Gap	-1.97
Depreciation Amortization	294,000,000
Dollar Volume	48,295,167.4
Earnings Date	2026-05-07
EBIT	EUR 1.4B
EBITDA	EUR 1.7B
EPS	EUR 0.61
F Score	6
FCF	EUR 753M
FCF EV Yield	4.45x
FCF Per Share	EUR 1.11
Financing CF	-501,000,000
Fiscal Year End	December
Founded	1,909
Graham Number	13.77596
Graham Upside	54.09
Income Tax	EUR 116M
Investing CF	-523,000,000
Is Primary Listing	1
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2016-01-04
Last Split Type	Forward
Lynch Fair Value	EUR 3.34
Lynch Upside	-62.65
Ma150	10.47
Ma150ch	-14.63%
Ma20	9.12
Ma20ch	-1.98%
Net CF	-51,000,000
Open	8.98
P FCF Ratio	7.38
P OCF Ratio	5.44
Payment Date	2025-08-13
Position In Range	64.71
Ppne	3,163,000,000
Price Date	2026-05-08
Price EBITDA	EUR 3.31
Relative Volume	2.35x
Revenue	7,438,000,000x
Tax By Revenue	1.56x
Tax Rate	18.99%
Tr6m	-13.79%
Volume	5,402,144
Z Score	1.11

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BME/GRF dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.4%

$0.30 annual per share

Payout ratio

+30.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-22.2%

0 consecutive years of growth

Total shareholder yield

+3.4%

Next ex-dividend date: 2025-08-11

Performance

BME/GRF stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BME/GRF?

Insider, institutional, and short-interest positioning.

Institutional ownership

+46.5%

Share of float held by funds and institutions

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

BME/GRF momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.9

Neutral momentum band

Price vs 200-day MA

-18.3%

50/200-day relationship not available

Beta (5Y)

1.17

Moves roughly with the market

Sharpe ratio

0.06

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BME/GRF

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bme/GRF stock rating?

bme/GRF is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bme/GRF analysis?

The full report lives at /stocks/bme/GRF/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bme/GRF?

The latest report frames bme/GRF around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bme/GRF page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.